The largest database of trusted experimental protocols

4 protocols using rhoa 2117

1

Investigating miR-650 Regulatory Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
MTT was purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Four synthetic, chemically modified short double-stranded RNA oligonucleotides (miR-650 mimics, mimics negative control, miR-650 inhibitor and inhibitor negative control) were obtained from Guangzhou RiboBio Co., Ltd. (Guangzhou, China). Primary antibodies against p38 (#9212), phosphorylated (p)-p38 (#4511), ERK1/2 (#4695), p-ERK1/2 (#4370) and RhoA (#2117) were obtained from Cell Signaling Technology, Inc. (Danvers, MA, USA); active Rac1 (#26903) and active RhoA (#26904) from NewEast Biosciences (King of Prussia, PA, USA); E-cadherin (ab1416), β-catenin (ab32572), Rac1 (ab33186) and FITC-conjugated anti-rat (ab6717)/anti-mouse IgG (ab6785) secondary antibodies from Abcam (Cambridge, UK); α-smooth muscle actin (α-SMA, 55135–1-AP) from ProteinTech Group, Inc. (Chicago, IL, USA); vimentin (BM0135) from Wuhan Boster Biological Technology, Ltd. (Wuhan, China); and β-actin (sc-58673) and HRP conjugated goat anti-rabbit/goat anti-mouse secondary antibodies (sc-2004/sc-2005) from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). The primary antibody ING4 (#40-7700) and the fluorescent dye Alexa Fluor 546 conjugated phalloidin (A22283, 1:5,000) were purchased from Invitrogen (Thermo Fisher Scientific, Inc., Waltham, MA, USA).
+ Open protocol
+ Expand
2

Cell Motility Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell motility assay was carried out as previously described31 (link). The changes in the expression of motility related proteins were analyzed by western blot analysis using primary antibodies against Rac1/2/3 (#2465), RhoA (#2117), Cdc42 (#2466), Src (#2109), p-Src (#2101), FAK (#3285), p-FAK (#8556), ERK (#4695), p-ERK (#4370) were purchased from Cell Signaling Technology (Tokyo, Japan). The experiments were carried out in triplicate.
+ Open protocol
+ Expand
3

Western Blot for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell lysates were prepared using RIPA lysis buffer (50 mM Tris–HCl, pH 7.5, 150 mmol/L NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 10 mmol/L EDTA), supplemented with complete EDTA-free protease inhibitor mixtures (4693116001, Roche, Indianapolis, IN, USA) and phosphatase inhibitors (04906845001, Roche). Protein samples were separated on SDS-polyacrylamide gels. For Western blot, separated proteins were transferred electrophoretically onto nitrocellulose membranes (ISEQ00010, Millipore, Sigma). The membranes were incubated overnight at 4 °C with antibodies against TIMP1 (16644-1-AP) from Proteintech (Rosemont, IL, USA); integrin β1 (sc-59829) and CD63 (sc-5275) from Santa Cruz Biotechnology (Dallas, TX, USA); VE-cadherin (ab33168), pFAK pY397 (ab81298) and total FAK (ab40794) from Abcam (Cambridge, UK); ZO-1 (40–2200), occludin (710192) and claudin-5 (35–2500) from Thermo Fisher Scientific; RhoA (2117) and Na/K ATPase (3010) from Cell Signaling Technology (Danvers, MA, USA). Following anti-mouse or anti-rabbit IgG-HRP (Thermo Fisher Scientific) were used as secondary antibodies for 1 h at room temperature, signals were detected using ImageQuant LAS 4000 (GE Healthcare).
+ Open protocol
+ Expand
4

Vasodilation Pathway Antibody Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against Rac1 (610651) and eNOS/NOS (610297) were from BD Biosciences. Anti‐MYPT1 (2634), P‐Pak (2605), Pak1 (2602), PDE5 (2395), PKG (3248), and RhoA (2117) antibodies were from Cell Signaling Technology. Anti‐P‐MYPT (sc17556), p116RIP3 (sc135494) and PSer188‐RhoA (sc32954) antibodies were from Santa Cruz Biotechnology. Anti‐soluble guanylyl cyclase sGCα1 (G4280) and sGCβ1 (G4405) antibodies were from Sigma. Anti‐eGFP antibody was from Clontech (632569). All agonists used for the analysis of blood vessels reactivity and vSMC treatment were from Sigma when not specified.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!